S. Dhingra and M. Sachdeva, “Expanding horizons in the treatment of mantle cell lymphoma: Ibrutinib a novel BTK-targeting inhibitor”, Int J Basic Clin Pharmacol, vol. 3, no. 1, pp. 249–254, Jan. 2017.